Dodge's aggressive shift away from the path of electrification that it previously put itself on is continuing. According to a new report from Mopar Insiders, the automaker is cancelling plans to build ...

Just ahead of the launch of Ghost of Yōtei on the PS5 next week, Sony is holding its latest State of Play showcase to detail what’s coming next for the platform. A cool-looking game with a very weird ...

Osaka (Jiji Press) — Kubota Corp. unveiled a concept model of its unmanned agriculture tractor powered by a hydrogen fuel cell, at the World Exposition in Osaka, a city in western Japan, on Monday. It ...

The 71st running of the Kubota High Limit Racing Gold Cup Race of Champions returns to Silver Dollar Speedway in Chico, California this weekend. Race fans have been gearing up for this event for ...

The new facility will cater to both domestic and international markets. The Yamuna Expressway Industrial Development Authority (YEIDA) has allotted 200 acres of land in Sector-10 to Escorts Kubota ...

Kubota Tractors, famous for its bright orange farming equipment, is owned by the larger Kubota Corporation. The Kubota Corporation is headquartered in Osaka, Japan, and it has been ever since Kubota's ...

Ahead of their long-awaited new album Inertia, drum'n'bass rock crew Pendulum have announced they'll be returning to the United Kingdom this November for a string of five shows. Kicking off at the ...

Pendulum have unleashed a brand-new single, Cannibal, featuring WARGASM. The two combine for a new banger taken from the drum’n’bass titans’ forthcoming album Inertia, which is due out on August 22 ...

General Sir Cecil Frederick Nevil Macready hated Ireland. He had a sense of foreboding when summoned to Downing Street in March 1920, fearing it had something to do with “the island I had hoped never ...

The trucking industry is facing a tepid financial outlook amid volatile market conditions compelled by the ongoing tariff-fueled global trade war, experts said. DAT Freight & Analytics found in its ...

As favor in the general market swings away from cell therapy, Immatics’ CEO is choosing to focus on what he can control: raising the bar for his biotech’s investigational treatment. “I at least ...